Preventing Infant RSV: Examining Opportunities for Monoclonal Antibody Products in the Vaccines for Children Program
This content is restricted to members only. Please login below.
Respiratory Syncytial Virus (RSV) is a leading cause of hospitalizations for infants and young children. Infections from RSV lead to 100-300 deaths, 58,000-80,000 hospitalizations, 520,000 emergency department visits, and 2.1 million out-patient visits among children younger than five years old…
The COVID-19 pandemic has heightened the importance of the 2020-21 flu vaccination campaign. Recent research suggests that having flu and COVID-19 doubles the risk of death, which is why promoting flu vaccination is so critical this season. Improving flu vaccination…